Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
Headlines
The 14th Lu Daopei Hematology Forum丨Professor Huili Zhu: Evidence-Based Updates and Precision Prevention and Control — A Clinical Interpretation of the 7th Edition of the Guidelines for Invasive Fungal Disease in Hematologic Disorders
2026.08.28
The 14th Lu Daopei Hematology Forum | Professor Hui Wang: Building the Foundation with Precision Diagnosis, Advancing with Intelligent Empowerment—The Clinical Value and Future Directions of Hematologic Laboratory Testing
2026.08.28
The 14th Lu Daopei Hematology Forum | Peihua Lu: Fourteen Years of Staying True to the Mission and Embarking on a New Journey—The Value and Future of an Academic Platform for Hematology
2026.08.28
The 14th Lu Daopei Hematology Forum | Dongchu Wang: Unlocking the Predictive Value of Cytokines and Optimizing the Entire Treatment Pathway—Research and Prospects of CD7 CAR-T as a Bridge to Transplantation
2026.08.28
The 14th Lu Daopei Hematology Forum | Dr. Shu Yan: Stratified Prevention and Control, Comprehensive Management—Strategies for the Diagnosis and Treatment of Invasive Fungal Disease After Hematopoietic Stem Cell Transplantation
2026.08.28
The 14th Lu Daopei Hematology Forum | Dr. Jiujiang He: Establishing Venetoclax as a Cornerstone and Exploring Standardized Practice—Clinical Applications and Future Perspectives of Venetoclax in AML
2026.08.27
the 14th Lu Daopei Hematology Forum丨Dr. Xiaosu Zhou: Decoding the “Genetic Code” of Atypical APL — Far Greater Complexity and Heterogeneity Than Expected
2026.08.27
Frontiers in Immunology | Germline Genetic Susceptibility Genes May Enable More Precise Donor Selection for Hematopoietic Stem Cell Transplantation — Clinical Insights from a 558-Patient Transplant Cohort
2026.08.27
Nature Reviews | The International Chinese Young Scholars Alliance for the Study of the Liver Facilitates Global Collaboration
2026.08.27
ESMO 2026丨Looking Ahead: A Quick Review of 26 Chinese Hematologic Oncology Studies Featured at ESMO
2026.08.27
Posted inHematology Frontier

The 14th Lu Daopei Hematology Forum丨Professor Huili Zhu: Evidence-Based Updates and Precision Prevention and Control — A Clinical Interpretation of the 7th Edition of the Guidelines for Invasive Fungal Disease in Hematologic Disorders

Posted by By Peter W. PENG 2026.08.28
Continue Reading
Posted inHematology Frontier IOncology

The 14th Lu Daopei Hematology Forum | Professor Hui Wang: Building the Foundation with Precision Diagnosis, Advancing with Intelligent Empowerment—The Clinical Value and Future Directions of Hematologic Laboratory Testing

Posted by By Mourabit Halima 2026.08.28
Continue Reading
EBMT 2025 | Post-Transplant Outcomes in AML with Haploidentical Donors

EBMT 2025 | Post-Transplant Outcomes in AML with Haploidentical Donors

Posted by By Mourabit Halima 2025.04.15
At the 51st Annual Meeting of EBMT, Dr. Eduardo Rodríguez-Arbolí presented important long-term data from an ALWP-EBMT study focusing on patients with acute myeloid leukemia (AML) who underwent haploidentical HSCT…
Read More
EAU25 | Final Survival Results from SPCG-13 Trial: Surveillance vs. Docetaxel After Radiotherapy in High-Risk Prostate Cancer

EAU25 | Final Survival Results from SPCG-13 Trial: Surveillance vs. Docetaxel After Radiotherapy in High-Risk Prostate Cancer

Posted by By Peter W. PENG 2025.04.15
In a Game Changer Session at EAU25, Prof. Kellokumpu-Lehtinen Pirkko-Liisa presented the 10-year follow-up from the Scandinavian Prostate Cancer Study Group-13 trial (SPCG-13), exploring adjuvant docetaxel versus surveillance following curative…
Read More
Can a short video ease the mind of a worried parent?

Can a short video ease the mind of a worried parent?

Posted by By Mourabit Halima 2025.04.15
At EAU25, Dr. Mehmet Cetin from Marmara University School of Medicine (Istanbul) presented a prospective randomized controlled study evaluating the impact of video-based informed consent on the anxiety levels of…
Read More
APASL China Voice | Dr. Rong Fan: The Application of Cell-Free DNA Testing in Early Hepatocellular Carcinoma Surveillance

APASL China Voice | Dr. Rong Fan: The Application of Cell-Free DNA Testing in Early Hepatocellular Carcinoma Surveillance

Posted by By Lisa Cui 2025.04.14
Editor’s Note: Hepatocellular carcinoma (HCC) is the sixth most common cancer worldwide and the third leading cause of cancer-related deaths. The overall prognosis for HCC remains poor, with a five-year…
Read More
APASL 2025 | Dr. Yinying Lu’s Team Unlocks New Multidimensional Strategies in Liver Cancer Treatment

APASL 2025 | Dr. Yinying Lu’s Team Unlocks New Multidimensional Strategies in Liver Cancer Treatment

Posted by By Mourabit Halima 2025.04.14
Editor’s Note: The 34th Annual Meeting of the Asian Pacific Association for the Study of the Liver (APASL 2025) concluded successfully on March 30. Following the events in Beijing (2010)…
Read More
Allogeneic Transplant Outcomes in Severe Aplastic Anemia: What Role Does Donor Type Play?

Allogeneic Transplant Outcomes in Severe Aplastic Anemia: What Role Does Donor Type Play?

Posted by By Mourabit Halima 2025.04.14
At the EBMT 2025 Annual Meeting, Dr. Juan Montoro Gómez (La Fe University and Polytechnic Hospital, Valencia) presented key findings from a comparative study led by the SAAWP of the…
Read More
Relapsed B-ALL Post CAR-T Therapy: Addressing a Growing Clinical Challenge | EBMT 2025

Relapsed B-ALL Post CAR-T Therapy: Addressing a Growing Clinical Challenge | EBMT 2025

Posted by By Mourabit Halima 2025.04.14
In his EBMT 2025 presentation, Prof. Alessandro Rambaldi (University of Milan / ASST Papa Giovanni XXIII, Bergamo) offered valuable insight into one of the most pressing issues in hematologic oncology:…
Read More
Late Effects After Auto-HSCT in Autoimmune Diseases: A Call for Long-Term Monitoring

Late Effects After Auto-HSCT in Autoimmune Diseases: A Call for Long-Term Monitoring

Posted by By Peng Longmei 2025.04.14
At the EBMT 2025 annual meeting, Dr. Kirill Kirgizov presented findings from a comprehensive retrospective survey (GS2-10) on late complications following autologous hematopoietic stem cell transplantation (HSCT) for autoimmune diseases…
Read More
Clonal Hematopoiesis in Pediatric HCT Survivors: New Insights from Dr. Konradin Müskens at EBMT 2025

Clonal Hematopoiesis in Pediatric HCT Survivors: New Insights from Dr. Konradin Müskens at EBMT 2025

Posted by By Mourabit Halima 2025.04.13
At the 51st EBMT Annual Meeting, Dr.Konradin Müskens (Prinses Máxima Centrum voor kinderoncologie, Netherlands) presented findings from the GS2-4 session on “Prevalence and Origin of Clonal Hematopoiesis in Long-Term Survivors…
Read More
Understanding Relapse After Allo-HCT: Dr. Luca Vago Sheds Light on Biological Complexity and Future Solutions

Understanding Relapse After Allo-HCT: Dr. Luca Vago Sheds Light on Biological Complexity and Future Solutions

Posted by By Peng Longmei 2025.04.13
At EBMT 2025, Dr. Luca Vago delivered a compelling presentation titled “Mechanisms of Leukemia Relapse after Allogeneic Transplantation: From Biology to Treatment (and Back).” His talk focused on the intricate…
Read More

Posts pagination

Previous page 1 … 20
Recent Posts
  • The 14th Lu Daopei Hematology Forum丨Professor Huili Zhu: Evidence-Based Updates and Precision Prevention and Control — A Clinical Interpretation of the 7th Edition of the Guidelines for Invasive Fungal Disease in Hematologic Disorders
  • The 14th Lu Daopei Hematology Forum | Professor Hui Wang: Building the Foundation with Precision Diagnosis, Advancing with Intelligent Empowerment—The Clinical Value and Future Directions of Hematologic Laboratory Testing
  • The 14th Lu Daopei Hematology Forum | Peihua Lu: Fourteen Years of Staying True to the Mission and Embarking on a New Journey—The Value and Future of an Academic Platform for Hematology
  • The 14th Lu Daopei Hematology Forum | Dongchu Wang: Unlocking the Predictive Value of Cytokines and Optimizing the Entire Treatment Pathway—Research and Prospects of CD7 CAR-T as a Bridge to Transplantation
  • The 14th Lu Daopei Hematology Forum | Dr. Shu Yan: Stratified Prevention and Control, Comprehensive Management—Strategies for the Diagnosis and Treatment of Invasive Fungal Disease After Hematopoietic Stem Cell Transplantation
Recent Comments
    Archives
    • August 2026
    • July 2026
    • June 2026
    • May 2026
    • April 2026
    • March 2026
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    Post You Might Like
    Posted inHematology Frontier
    The 14th Lu Daopei Hematology Forum丨Professor Huili Zhu: Evidence-Based Updates and Precision Prevention and Control — A Clinical Interpretation of the 7th Edition of the Guidelines for Invasive Fungal Disease in Hematologic Disorders
    Posted by By Peter W. PENG 2026.08.28
    Posted inHematology Frontier IOncology
    The 14th Lu Daopei Hematology Forum | Professor Hui Wang: Building the Foundation with Precision Diagnosis, Advancing with Intelligent Empowerment—The Clinical Value and Future Directions of Hematologic Laboratory Testing
    Posted by By Mourabit Halima 2026.08.28
    Posted inIOncology
    The 14th Lu Daopei Hematology Forum | Peihua Lu: Fourteen Years of Staying True to the Mission and Embarking on a New Journey—The Value and Future of an Academic Platform for Hematology
    Posted by By Mourabit Halima 2026.08.28
    Posted inHematology Frontier
    The 14th Lu Daopei Hematology Forum | Dongchu Wang: Unlocking the Predictive Value of Cytokines and Optimizing the Entire Treatment Pathway—Research and Prospects of CD7 CAR-T as a Bridge to Transplantation
    Posted by By Mourabit Halima 2026.08.28
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top

    Welcome to Mediamedic 👋
    It’s nice to meet you.

    Dive into a world of trusted health insights. Subscribe for monthly updates straight to your inbox

    Privacy is part of our care. No spam, just wellness.

    🔒 Privacy policy

    Check your inbox or spam folder to confirm your subscription.

    • Facebook
    • X (Twitter)
    • LinkedIn
    • More Networks
    Share via
    Facebook
    X (Twitter)
    LinkedIn
    Mix
    Email
    Print
    Copy Link
    Copy link
    CopyCopied